CombinatoRx
A biotech company that develops medicines from synergistic combinations of approved drugs.
Launch date
Market cap
-
Enterprise valuation
CAD164—245m (Dealroom.co estimates Mar 2004.)
Cambridge Massachusetts (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
$40.0m | Series B | ||
$30.0m | Series C | ||
N/A | Acquisition | ||
| Total Funding | CAD95.5m | ||